FFA
PBYI icon

Farther Finance Advisors’s Puma Biotechnology PBYI Stock Holding History

Farther Finance Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.6K Buy
1,182
+616
+109% +$4.51K ﹤0.01% 4446
2026
Q1 		$3.83K Buy
566
+37
+7% +$239 ﹤0.01% 4626
2025
Q4 		$3.15K Buy
+529
New +$2.81K ﹤0.01% 4514

Other funds holding PBYI

PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
HP
Haven Private Orlando, Florida $263M AUM 21.06% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return
DOA
D'Orazio & Associates Falls Church, Virginia $864M AUM 21.64% 1-Year Est. Return
BWM
Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CWM
C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Farther Finance Advisors's PBYI Position: Q2 2026 in Review

Farther Finance Advisors increased its Puma Biotechnology (PBYI) stake by 109% in Q2 2026, buying an estimated $4.51K and bringing the position to 1,182 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4446.

Farther Finance Advisors first reported a position in PBYI in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Farther Finance Advisors held 1,182 shares of Puma Biotechnology worth $9.6K as of Q2 2026.
  • Farther Finance Advisors bought 616 Puma Biotechnology shares in Q2 2026, an estimated $4.51K.
  • Puma Biotechnology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4446 holding.
  • Farther Finance Advisors first reported a position in Puma Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.